Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Electronic Records Enforcement Relaxed During Part 11 Review, FDA Says

Executive Summary

FDA intends to relax enforcement of its Part 11 regulation on electronic records while it reexamines the rule's application, a draft guidance document states
Advertisement

Related Content

GMP Quality Management Systems For FDA Will Be Proposed By December
GMP Quality Management Systems For FDA Will Be Proposed By December
FDA Should Allow Third-Party Electronic Storage Of Clinical Data – PhRMA
FDA Should Allow Third-Party Electronic Storage Of Clinical Data – PhRMA
FDA GMP Initiative Shifts Warning Letter Review Back To Agency Centers
FDA Part 11 Policy Should Take Risk-Based Approach, PhRMA Says
PAT Guidance Will Draw From Existing Guidances On Electronic Records
Lilly GMP “Culture Change” Will Address Compliance Issues, Firm Tells FDA
Lilly GMP “Culture Change” Will Address Compliance Issues, Firm Tells FDA
Advertisement
UsernamePublicRestriction

Register

PS041348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel